Keratoderma Palmaris et Plantaris â A Comprehensive Medical Guide
Overview
Keratoderma palmaris et plantaris (KPPP) is a group of hereditary or acquired skin disorders that cause abnormal thickening (hyperkeratosis) of the skin on the palms of the hands and the soles of the feet. The condition may appear as diffuse, patchy, or focal thickening and can be associated with pain, fissuring, or reduced grip. While many cases are inherited in an autosomalâdominant pattern, KPPP can also develop secondary to systemic diseases, infections, or medication exposure.
Who it affects: Most cases present in childhood or early adulthood, but lateâonset forms have been reported. Both sexes are affected equally, although certain genetic subtypes (e.g., Vohwinkel syndrome) show a slight male predominance.
Prevalence: Exact global prevalence is unknown because KPPP is rare and often underâdiagnosed. Epidemiologic surveys estimate a prevalence of roughly 1â2 per 100,000 individuals for the more common autosomalâdominant forms, while rare syndromic variants occur in <0.1 per 100,000.[1] WHO, 2022
Symptoms
Symptoms vary by subtype and severity. Below is a comprehensive list:
Skinârelated signs
- Diffuse hyperkeratosis: Uniform thickening of the entire palm and/or sole.
- Focal plaques: Wellâdefined, raised, waxy lesions that may have a "rainâdrop" or "pebbleâlike" appearance.
- Vesicles or pustules: Occasionally appear before thickening, especially in epidermolytic variants.
- Fissuring: Deep cracks in the skin that can bleed or become infected.
- Palmar/plantar hyperhidrosis: Excessive sweating that worsens maceration.
- Palmar creases: May be deepened or obscured by thick skin.
Pain & functional impact
- Burning or tenderness when walking or using hands.
- Reduced grip strength and dexterity.
- Difficulty wearing shoes, leading to callus formation on toes.
Associated systemic features (in syndromic forms)
- Hearing loss (e.g., in Vohwinkel syndrome).
- Nail dystrophy or onycholysis.
- Dental anomalies, short stature, or cardiac defects depending on the genetic mutation.
Causes and Risk Factors
Genetic causes (hereditary KPPP)
More than 15 genes have been implicated. The most common include:
- KRT9 â Keratin 9 mutations cause classic epidermolytic palmoplantar keratoderma.
- GJB2 â Connexin 26 mutations lead to Vohwinkel syndrome.
- SLURP1 â Causes Mal de Meleda, an autosomalârecessive diffuse keratoderma.
- AQP5, AQP9 â Aquaporin channel mutations linked to aquagenic keratoderma.
Inheritance patterns are usually autosomal dominant, but autosomal recessive and Xâlinked forms exist.[2] NIH Genetics, 2023
Acquired causes
- Systemic diseases: Psoriasis, eczema, ichthyosis, lupus, or endocrine disorders (thyroid disease, diabetes).
- Infections: Chronic fungal (tinea pedis/manuum) or bacterial infections.
- Medications: Longâterm retinoids, penicillamine, or arsenic exposure.
- Physical factors: Repeated mechanical pressure (e.g., manual labor, sports), excessive heat, or chronic moisture.
Risk factors
- Family history of palmoplantar keratoderma.
- Occupations with heavy hand/foot use (construction, mechanics, athletes).
- Underlying skin conditions (psoriasis, atopic dermatitis).
- Uncontrolled diabetes or peripheral vascular disease.
Diagnosis
Diagnosing KPPP involves a combination of clinical assessment, family history, and targeted investigations.
Clinical evaluation
- History: Onset age, progression, family members with similar findings, exposure to irritants, and systemic symptoms.
- Physical exam: Detailed inspection of palms and soles, documentation of distribution, thickness, fissuring, and any extraâcutaneous signs.
Dermatologic tools
- Dermoscopy: Reveals characteristic patterns (e.g., âcobblestoneâ or âsnowflakeâ hyperkeratosis).
- Skin biopsy: Histology shows hyperkeratosis, acanthosis, and, in epidermolytic variants, vacuolated keratinocytes with eosinophilic granules.
Genetic testing
When a hereditary form is suspected, nextâgeneration sequencing panels targeting KRT9, GJB2, SLURP1, and related genes are recommended. In many countries, testing is covered when a clear family pattern exists.[3] Cleveland Clinic, 2024
Laboratory & imaging (for acquired forms)
- Baseline blood work (CBC, fasting glucose, thyroid panel) to rule out systemic disease.
- Fungal culture or KOH prep if a tinea infection is suspected.
- Radiographs only if there is suspicion of underlying bony involvement (rare).
Treatment Options
Therapy is individualized based on severity, underlying cause, and patient preferences.
Topical agents
- Urea 10â40% creams: Softens hyperkeratotic plaques; applied twice daily.
- Salicylic acid 2â6%: Keratolytic; useful for focal plaques.
Systemic medications
- Oral retinoids (acitretin, isotretinoin): Firstâline for widespread, refractory disease. Typical dose: acitretin 0.5â1âŻmg/kg/day. Monitor liver function, lipids, and pregnancy status.
- Lowâdose methotrexate: Considered when inflammatory components dominate (e.g., psoriatic KPPP).
- Biologic agents: Limited data, but case reports suggest efficacy of ILâ17 or ILâ23 inhibitors in keratoderma associated with psoriasis.
Procedural interventions
- Mechanical debridement: Salabrasion or gentle filing to remove excess keratin under medical supervision.
- Laser therapy: COâ or Er:YAG lasers can precisely ablate thickened skin with minimal downtime.
- Photodynamic therapy (PDT): Emerging option for focal lesions.
Adjunctive measures
- Moisturizing regimen: Thick, fragranceâfree emollients (e.g., petrolatum, ceramideârich creams) immediately after bathing.
- Foot/hand orthoses: Cushioned insoles, padded gloves, or custom shoe inserts to reduce pressure.
- Hyperhidrosis control: Aluminium chloride antiperspirants, iontophoresis, or botulinum toxin injections for excessive sweating.
Lifestyle & selfâcare
Adopt a regimen of gentle exfoliation (e.g., pumice stone after soaking) 2â3 times/week, keep nails trimmed, and avoid walking barefoot on rough surfaces.
Living with Keratoderma Palmaris et Plantaris
Daily skinâcare routine
- Morning: Warm water soak (5â10âŻmin), apply urea cream, and gently pat dry.
- Midâday: Reâapply a thin layer of emollient if hands/feet become dry.
- Evening: Repeat soak, followed by a heavier moisturizer or nightâtime occlusive dressing (e.g., gauze soaked in petroleum jelly).
Footwear tips
- Choose breathable, cushioned shoes with a wide toe box.
- Rotate shoes every 2â3 days to allow drying.
- Use moistureâwicking socks (cotton or bamboo) and change them if they become damp.
Workâplace adaptations
- Wear protective gloves with a soft lining for repetitive manual tasks.
- Take short, frequent breaks to relieve pressure.
- Use antiâfatigue mats if standing for long periods.
Psychosocial coping
Visible skin changes can affect confidence. Consider counseling, support groups, or patientâled forums (e.g., RareSkin.org). Many patients find relief in documenting improvement with photos, which can also help clinicians adjust therapy.
Prevention
While hereditary forms cannot be prevented, several strategies lessen severity and reduce the risk of secondary complications:
- Maintain optimal skin hydrationâapply emollients immediately after baths.
- Avoid chronic exposure to irritants (strong detergents, solvents). Use gloves when handling chemicals.
- Control hyperhidrosis early; excess moisture softens the stratum corneum and promotes maceration.
- Treat any underlying fungal or bacterial infection promptly.
- For families with known mutations, genetic counseling before pregnancy can provide reproductive options (preâimplantation genetic testing, donor gametes).
Complications
If left untreated or poorly managed, KPPP may lead to:
- Infections: Bacterial cellulitis, Staphylococcus aureus or Streptococcus infections of fissures.
- Secondary fungal overgrowth: Tinea pedis/manuum, especially in moist environments.
- Mobility limitations: Painful walking or grip loss can affect daily activities and employment.
- Ulceration: Deep fissures may progress to chronic ulcers, particularly in diabetics.
- Psychological impact: Depression or anxiety due to cosmetic concerns.
When to Seek Emergency Care
- Rapid spreading redness, swelling, or warmth around the palms/soles accompanied by fever (>38âŻÂ°C / 100.4âŻÂ°F).
- Severe, uncontrolled pain that does not improve with overâtheâcounter analgesics.
- Signs of a deep infection: pus, foul odor, or an ulcer that is rapidly enlarging.
- Sudden loss of sensation or motor function in the hands or feet.
- Any indication of systemic toxicity (e.g., confusion, rapid heartbeat) after starting systemic retinoids or other medications.
Early treatment of acute infections or complications can prevent permanent damage.
References
- World Health Organization. âRare Skin Disorders: Global Estimates.â WHO Press, 2022.
- National Institutes of Health â Genetics Home Reference. âKeratoderma Palmaris et Plantaris.â Updated 2023.
- Cleveland Clinic. âGenetic Testing for Palmoplantar Keratoderma.â Patient Education, 2024.
- Mayo Clinic. âRetinoids: Uses, Side Effects, and Precautions.â 2023.
- American Academy of Dermatology. âManagement of Palmoplantar Keratoderma.â Clinical Practice Guidelines, 2023.